Epigene Labs
Epigene Labs is a biotechnology company focused on accelerating precision oncology research and drug development through its AI-powered mCUBE platform. This platform aggregates and analyzes comprehensive oncology data from multiple sources, providing a high-resolution, multi-dimensional view of disease biology to aid in drug discovery, target identification, and patient stratification. By reducing R&D timelines and increasing the probability of success, Epigene Labs aims to deliver more effective and personalized cancer treatments. The company, founded in 2019 and with a team of 24 employees, is based in Paris and Boston, having been incubated at Harvard Innovation Labs and securing significant funding and grants. Epigene Labs partners with biopharmaceutical companies and research institutions to advance its mission.
Epigene Labs
Epigene Labs is a biotechnology company focused on accelerating precision oncology research and drug development through its AI-powered mCUBE platform. This platform aggregates and analyzes comprehensive oncology data from multiple sources, providing a high-resolution, multi-dimensional view of disease biology to aid in drug discovery, target identification, and patient stratification. By reducing R&D timelines and increasing the probability of success, Epigene Labs aims to deliver more effective and personalized cancer treatments. The company, founded in 2019 and with a team of 24 employees, is based in Paris and Boston, having been incubated at Harvard Innovation Labs and securing significant funding and grants. Epigene Labs partners with biopharmaceutical companies and research institutions to advance its mission.
TL;DR
Headquarters: Paris and Boston
Founded: 2019
Product: mCUBE — AI platform for harmonizing multi-omic cancer data
Focus: Precision oncology R&D: target discovery, biomarker ID, patient stratification
Recent financing: Convertible note on 2023-09-29; investors include European Innovation Council, daphni, XAnge, Majycc Innovation Santé, AGORANOV
Company Overview
Problem Domain
Precision oncology research and drug development (multi-omic data integration and analysis).
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Latest listed funding event on public profiles
Investor Signal
“Investors include European Innovation Council, daphni, XAnge, Majycc Innovation Santé, AGORANOV”